Hairy Cell Leukemia: 2026 Update on Diagnosis, Risk‐Stratification, and Treatment

Study limitation reported by the research below: “HCL-V and SDRPL are discussed alongside classic HCL, but they have distinct biology and prognosis; recommendations may not apply uniformly across all three entities.”